Pathophysiology of inflammatory and autoimmune myopathies.
about
Vitamin D receptor agonists: suitable candidates as novel therapeutic options in autoimmune inflammatory myopathyPolymyositis following Pandemic Influenza A (H1N1) and 2009-10 Seasonal Trivalent VaccinesComplement membrane attack complex is related with immune-mediated necrotizing myopathy.Diffuse cutaneous mucinosis in dermatomyositis: a case report and review of the literature.Diagnosis and treatment of inflammatory myopathy: issues and management.A rare association of early-onset inclusion body myositis, rheumatoid arthritis and autoimmune thyroiditis: a case report and literature review.Chronic inflammatory muscle diseases and risk of coronary artery disease.Current pharmacological treatment of idiopathic inflammatory myopathies.Autocrine and immune cell-derived BDNF in human skeletal muscle: implications for myogenesis and tissue regeneration.Infections and vaccinations as possible triggers of inflammatory myopathies.Epidemiologic analysis of the clinical features of Japanese patients with polymyositis and dermatomyositis.Acute rejection of myofibers in nonhuman primates: key histopathologic features.Apparent diffusion coefficient (ADC) does not correlate with different serological parameters in myositis and myopathy.Statin-associated immune-mediated necrotising myopathy: a New Zealand case series showing possible overrepresentation in Pacific Islanders.The PTPN22 gene is associated with idiopathic inflammatory myopathy.Associations between apparent diffusion coefficient and electromyography parameters in myositis-A preliminary study.Serum Interleukin-18 Level is Associated With Disease Activity and Interstitial Lung Disease in Patients With Dermatomyositis
P2860
Q26849424-8FA9395E-3E17-4BB0-8E27-539F8F535976Q30420816-38966D13-26F8-4817-9797-B2597BED06ADQ34029161-56E7A916-8842-4586-9C64-3B2CD4471173Q34609997-806ED8A2-157C-4011-A628-C6CCE9C9A667Q36059517-1C6B9F99-919F-42DB-97CD-7DDE2DD5EF44Q37267141-05FCFC2C-B890-4F74-8C10-FA8CB6141367Q38076079-DA0FAB3E-05CA-4178-B79D-F972FE2E42E0Q38680762-4BC0E015-6BA3-4225-890E-3471584F4243Q39138300-8942FDA2-3894-4FC9-BD7F-2613FE01251FQ40322503-96F9B5AE-5FB1-49C4-BD36-7106D9CD600FQ40534854-8DE09D7A-4A06-44A9-BD90-5720434E9C3CQ45878414-4D492907-A92C-4C29-88AF-DE76A81386CBQ47816180-E21B790B-F7C4-4945-B5B8-4CF7CD2803B8Q48283527-18180BDF-A413-4F14-B679-8FEA3FAE6814Q51698814-C185D1C1-C60B-4BD4-896A-DDE7D5CD5753Q55525301-A967EDC6-1D3B-4924-ACE9-A500A5E9307EQ58133773-6FEDDD6F-4AAF-4F48-A5E1-05BE46F228E3
P2860
Pathophysiology of inflammatory and autoimmune myopathies.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 March 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pathophysiology of inflammatory and autoimmune myopathies.
@en
Pathophysiology of inflammatory and autoimmune myopathies.
@nl
type
label
Pathophysiology of inflammatory and autoimmune myopathies.
@en
Pathophysiology of inflammatory and autoimmune myopathies.
@nl
prefLabel
Pathophysiology of inflammatory and autoimmune myopathies.
@en
Pathophysiology of inflammatory and autoimmune myopathies.
@nl
P1433
P1476
Pathophysiology of inflammatory and autoimmune myopathies.
@en
P2093
Marinos C Dalakas
P304
P356
10.1016/J.LPM.2011.01.005
P433
P577
2011-03-15T00:00:00Z